Adam Freund 11/11/24 Adam Freund 11/11/24

Arda presents at 8th Annual Antifibrotics Drug Development Conference

Adam Freund 10/30/24 Adam Freund 10/30/24

Arda CEO Adam Freund and CTO Rémi Laberge on Translating aging podcast

Adam Freund 10/9/24 Adam Freund 10/9/24

Arda Therapeutics Secures $43M Series A Financing to Advance Targeted Cell Depletion Therapies

Funding led by Andreessen Horowitz (a16z) Bio + Health, with participation from Two Sigma Ventures, RV Invest, Eli Lilly and Company, GV and other leading investors

Globally recognized R&D leader Scott Turner, Ph.D., joins Arda as chief scientific officer

Adam Freund 8/20/24 Adam Freund 8/20/24

Arda presents at 8th Annual IPF Summit

Adam Freund 11/17/23 Adam Freund 11/17/23

Arda presents at Longevity Summit

Adam Freund 10/9/23 Adam Freund 10/9/23

Arda presents at 7th Annual Antifibrotics Drug Development Conference

Adam Freund 6/3/23 Adam Freund 6/3/23

The past and present of aging biotech

On June 30, Arda CEO Adam Freund will be chatting with colleagues James Peyer, PhD and Kristen Fortney about the history of the longevity biotech industry and how we got to where we are today.